This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Università Degli Studi Di Firenze. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Nicoletta Cini: Innovator in Peptidomimetic Integrin Inhibitors
Introduction
Nicoletta Cini is a prominent inventor based in Florence, Italy. She has made significant contributions to the field of chemical compounds, particularly in the development of peptidomimetic integrin inhibitors. Her work focuses on innovative solutions for diagnosing and treating tumors.
Latest Patents
Nicoletta Cini holds a patent for "1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors." This invention pertains to chemical compounds featuring a 1,2,3-triazole ring and possessing guanidino and carboxylic groups or their isosteres. The preparation of these compounds is achieved through Cu-catalyzed 'click-chemistry.' The medical-diagnostic applications of this invention are particularly relevant in pathologies where angiogenesis is altered, such as tumor-related conditions, tumor metastasis, osteoporosis, and rheumatoid arthritis. She has 1 patent to her name.
Career Highlights
Nicoletta Cini is affiliated with the Università Degli Studi Di Firenze, where she continues her research and development in the field of chemical compounds. Her academic background and innovative approach have positioned her as a key figure in her area of expertise.
Collaborations
Nicoletta has collaborated with notable colleagues, including Antonio Guarna and Gloria Menchi. These partnerships have further enhanced her research and contributed to the advancement of her projects.
Conclusion
Nicoletta Cini is a trailblazer in the field of peptidomimetic integrin inhibitors, with a focus on innovative solutions for tumor diagnosis and therapy. Her contributions are paving the way for advancements in medical diagnostics and treatment options.